Design of nuclease resistant protein kinase Cα DNA enzymes with potential therapeutic application

Journal of Molecular Biology

Volumn 296, Issue 3, 2000, Pages 937-947

  Sioud, Mouldy ^a   Leirdal, Marianne ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apoptosis; Bcl x(L); DNA enzymes; PKC ; Ribozyme

Indexed keywords

DNA; FLUORESCEIN ISOTHIOCYANATE; MAGNESIUM; NUCLEASE; PHOSPHOROTHIOIC ACID; PROTEIN KINASE C; RIBOZYME; THYMIDINE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG DESIGN; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MODIFICATION; ENZYME STABILITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034711950     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3491     Document Type: Article

References (38)

1. Chemical modification of hammerhead ribozymes
2. Protein kinase C: A worthwhile target for anticancer drugs?
3. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
4. Translating genomics information into therapautics: A key role for oligonucleotides
5. Ribozyme mediated destruction of RNA in vivo
6. Inhibition of protein kinase Cα expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides
7. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase Cα expression
8. Identification of programmed cell death in situ via a specific labelling of nuclear DNA fragmentation
9. Simple RNA enzymes with new and highly specific endoribonuclease activities
10. High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates
11. Antisense oligonucleotide inhibitors for the treatment of cancer. 2. Toxicological properties of phosphorothioate oligonucleotides
12. Optimizing the cell efficacy of synthetic ribozymes
13. The proto-oncogene Bcl-2 and its role in regulating apoptosis
14. Ribozyme inhibition of the protein kinase Cα triggers apoptosis in glioma cells
15. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
16. Induction of apoptosis program in cell-free extracts: Requirement of dATP and cytochrome c
17. PKCα isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow
18. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-x(L) and caspase-3-like proteases
19. Protein kinase C: Structure, function and regulation
20. Imaging protein kinase Cα activation in cells
21. Elevated protein kinase C expression in human breast tumour biopsies relative to normal breast tissue
22. Study of a hammerhead ribozyme containing 2'-modified adenosine residues
23. Protein kinase C a family affair
24. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes
25. A functional role for mitochondrial protein kinase Cα in Bcl2 phosphorylation and suppression of apoptosis
26. A general purpose RNA-cleaving DNA enzyme
27. Ribozymes as potential anti HIV-1 therapeutic agents
28. Application of preformed hammerhead ribozymes in the gene therapy of cancer
29. Prevention of HIV-1 integrase expression in E. coli by a ribozyme
30. A nuclease-resistant protein kinase Cα ribozyme blocks glioma cell growth
31. A minimised hammerhead ribozyme with activity against interleukin-2 in human cells
32. Thermodynamic parameters to predict stability of RNA/DNA hybrid duplxes
33. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo
34. A small catalytic oligoribonucleotide
35. Gene inhibition using antisense oligonucleotides
36. MCF-7 breast cancer cells transfected with PKC-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
37. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
38. Loss of protein kinase C function induces an apoptotic response